vs

Side-by-side financial comparison of HERC HOLDINGS INC (HRI) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $30.1M, roughly 1.5× HERC HOLDINGS INC). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. runs the higher net margin — -90.4% vs -331.7%, a 241.2% gap on every dollar of revenue. On growth, HERC HOLDINGS INC posted the faster year-over-year revenue change (629.3% vs 13.8%). HERC HOLDINGS INC produced more free cash flow last quarter ($-14.3M vs $-19.9M).

Herc Holdings Inc. is a leading North American equipment rental service provider. It offers rental assets including heavy construction machinery, power tools, temporary power and climate control systems, serving clients across construction, industrial, events, infrastructure and government segments, with operations across the U.S. and Canada.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

HRI vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.5× larger
PACB
$44.6M
$30.1M
HRI
Growing faster (revenue YoY)
HRI
HRI
+615.4% gap
HRI
629.3%
13.8%
PACB
Higher net margin
PACB
PACB
241.2% more per $
PACB
-90.4%
-331.7%
HRI
More free cash flow
HRI
HRI
$5.6M more FCF
HRI
$-14.3M
$-19.9M
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HRI
HRI
PACB
PACB
Revenue
$30.1M
$44.6M
Net Profit
$-99.9M
$-40.4M
Gross Margin
42.3%
37.1%
Operating Margin
-77.4%
-92.3%
Net Margin
-331.7%
-90.4%
Revenue YoY
629.3%
13.8%
Net Profit YoY
-866.2%
-1802.7%
EPS (diluted)
$-0.36
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRI
HRI
PACB
PACB
Q4 25
$30.1M
$44.6M
Q3 25
$10.1M
$38.4M
Q2 25
$6.3M
$39.8M
Q1 25
$4.2M
$37.2M
Q4 24
$4.1M
$39.2M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
HRI
HRI
PACB
PACB
Q4 25
$-99.9M
$-40.4M
Q3 25
$-7.5M
$-38.0M
Q2 25
$-10.8M
$-41.9M
Q1 25
$-14.1M
$-426.1M
Q4 24
$-10.3M
$2.4M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
HRI
HRI
PACB
PACB
Q4 25
42.3%
37.1%
Q3 25
25.8%
41.4%
Q2 25
53.1%
36.9%
Q1 25
35.0%
-3.7%
Q4 24
21.4%
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
HRI
HRI
PACB
PACB
Q4 25
-77.4%
-92.3%
Q3 25
-153.5%
-101.1%
Q2 25
-147.4%
-112.8%
Q1 25
-242.7%
-1154.5%
Q4 24
-206.3%
-390.1%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
HRI
HRI
PACB
PACB
Q4 25
-331.7%
-90.4%
Q3 25
-74.1%
-98.9%
Q2 25
-171.4%
-105.4%
Q1 25
-332.8%
-1146.8%
Q4 24
-250.3%
6.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
HRI
HRI
PACB
PACB
Q4 25
$-0.36
$-0.11
Q3 25
$-0.03
$-0.13
Q2 25
$-0.08
$-0.14
Q1 25
$-0.15
$-1.44
Q4 24
$-0.15
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRI
HRI
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$550.7M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$437.8M
$5.3M
Total Assets
$1.1B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRI
HRI
PACB
PACB
Q4 25
$550.7M
$279.5M
Q3 25
$432.8M
$298.7M
Q2 25
$67.6M
$314.7M
Q1 25
$343.1M
Q4 24
$30.0M
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
HRI
HRI
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$300.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HRI
HRI
PACB
PACB
Q4 25
$437.8M
$5.3M
Q3 25
$486.1M
$36.1M
Q2 25
$90.8M
$61.5M
Q1 25
$26.1M
$91.6M
Q4 24
$16.6M
$506.6M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
HRI
HRI
PACB
PACB
Q4 25
$1.1B
$784.1M
Q3 25
$550.2M
$803.2M
Q2 25
$152.0M
$825.5M
Q1 25
$104.6M
$860.8M
Q4 24
$109.6M
$1.3B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B
Debt / Equity
HRI
HRI
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.02×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRI
HRI
PACB
PACB
Operating Cash FlowLast quarter
$-12.7M
$-19.1M
Free Cash FlowOCF − Capex
$-14.3M
$-19.9M
FCF MarginFCF / Revenue
-47.6%
-44.6%
Capex IntensityCapex / Revenue
5.3%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRI
HRI
PACB
PACB
Q4 25
$-12.7M
$-19.1M
Q3 25
$-11.0M
$-18.7M
Q2 25
$-8.4M
$-29.4M
Q1 25
$-6.7M
$-44.1M
Q4 24
$-8.1M
$-30.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
HRI
HRI
PACB
PACB
Q4 25
$-14.3M
$-19.9M
Q3 25
$-11.1M
$-18.8M
Q2 25
$-8.5M
$-29.9M
Q1 25
$-6.8M
$-45.4M
Q4 24
$-8.1M
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
HRI
HRI
PACB
PACB
Q4 25
-47.6%
-44.6%
Q3 25
-110.2%
-48.9%
Q2 25
-135.5%
-75.3%
Q1 25
-160.8%
-122.3%
Q4 24
-197.1%
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
HRI
HRI
PACB
PACB
Q4 25
5.3%
1.9%
Q3 25
1.7%
0.2%
Q2 25
1.5%
1.4%
Q1 25
4.0%
3.7%
Q4 24
0.7%
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
HRI
HRI
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRI
HRI

Sales Of New Equipment$9.0M30%
Sales Of Parts And Supplies$8.0M27%
Other$7.1M24%
Serviceand Other Revenue$6.0M20%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons